Status:
UNKNOWN
Different Regimens in Influenza Postexposure Chemoprophylaxis in Children
Lead Sponsor:
Centre of Postgraduate Medical Education
Conditions:
Influenza
Exposure
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
Although the vaccination is the preferred method of influenza prevention, there are some occasions on which a postexposure prophylaxis (PEP) is required. Two neuraminidase inhibitors (NAIs) may be use...
Detailed Description
Only applies to patients hospitalized due to other than influenza reasons. If a proven contact with influenza has taken place (influenza diagnosed by signs/symptoms and positive rapid influenza diagno...
Eligibility Criteria
Inclusion
- patients hospitalized at the Pediatric Ward
- age: 0-18 years old
- confirmed contact with a person diagnosed with influenza
- patient's, patient's parent/tutor's informed consent
Exclusion
- lack of an informed consent
- more than 48 hours after the first contact with influenza
- severe adverse reaction to the drug- discontinuation of the prophylaxis
- important to a parent/tutor drug intolerance (e.g. lack of tolerance of a drug's taste)
- new contact with influenza after chemoprophylaxis has finished
Key Trial Info
Start Date :
November 17 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04297462
Start Date
November 17 2016
End Date
December 31 2020
Last Update
September 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Centre of Postgraduate Medical Education
Warsaw, Masovian Voivodeship, Poland, 01-813